(Q37313734)

19 August 2017

1 reference

title

The prominent role of the liver in the elimination of asymmetric dimethylarginine (ADMA) and the consequences of impaired hepatic function (English)

1 reference

19 August 2017

Milan C Richir

1

1 reference

19 August 2017

Roderick H Bouwman

2

1 reference

19 August 2017

Tom Teerlink

3

1 reference

19 August 2017

Michiel P C Siroen

4

1 reference

19 August 2017

Theo P G M de Vries

5

1 reference

19 August 2017

Paul A M van Leeuwen

6

1 reference

19 August 2017

publication date

1 November 2008

1 reference

Journal of Parenteral and Enteral Nutrition

19 August 2017

published in

1 reference

19 August 2017

volume

32

1 reference

19 August 2017

issue

6

1 reference

19 August 2017

page(s)

613-621

1 reference

Enzymatic function of nitric oxide synthases

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Role of nitric oxide in sepsis-associated pulmonary edema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Nitric oxide (NO) protects against cellular damage by reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Nitric oxide of human colorectal adenocarcinoma cell lines promotes tumour cell invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Isoforms of nitric oxide synthase Characterization and purification from different cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Asymmetrical dimethylarginine: the Uber marker?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

ADMA and hyperhomocysteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

The clinical significance of asymmetric dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

ADMA metabolism and clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

S-Adenosylmethionine:protein-arginine methyltransferase. Purification and mechanism of the enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

State of the arg: protein methylation at arginine comes of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Vascular endothelial cells synthesize nitric oxide from L-arginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Endogenous Dimethylarginine as an Inhibitor of Nitric Oxide Synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Interference of L-arginine analogues with L-arginine transport mediated by the y+ carrier hCAT-2B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Urinary excretion of methylarginine in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

L-arginine regulates asymmetric dimethylarginine metabolism by inhibiting dimethylarginine dimethylaminohydrolase activity in hepatic (HepG2) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Chromosomal localization, gene structure, and expression pattern of DDAH1: comparison with DDAH2 and implications for evolutionary origins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Biological significance of endogenous methylarginines that inhibit nitric oxide synthases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Farnesoid X receptor agonist reduces serum asymmetric dimethylarginine levels through hepatic dimethylarginine dimethylaminohydrolase-1 gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

all-trans-Retinoic acid increases nitric oxide synthesis by endothelial cells: a role for the induction of dimethylarginine dimethylaminohydrolase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

European guidelines on cardiovascular disease prevention in clinical practice: executive summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Decreased levels of asymmetric dimethylarginine during acute hyperinsulinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Estrogen stimulates dimethylarginine dimethylaminohydrolase activity and the metabolism of asymmetric dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Oral, more than transdermal, oestrogen therapy lowers asymmetric dimethylarginine in healthy postmenopausal women: a randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Oestrogen replacement therapy lowers plasma levels of asymmetrical dimethylarginine in healthy postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Effect of hormone replacement therapy on plasma levels of the cardiovascular risk factor asymmetric dimethylarginine: a randomized, placebo-controlled 12-week study in healthy early postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Homocysteine increases the production of asymmetric dimethylarginine in cultured neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Protective effects of daviditin A against endothelial damage induced by lysophosphatidylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Impact of vitamin E on plasma asymmetric dimethylarginine (ADMA) in chronic kidney disease (CKD): a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Dimethylarginine dimethylaminohydrolase I enhances tumour growth and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Dimethylarginine dimethylaminohydrolase activity modulates ADMA levels, VEGF expression, and cell phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Detection of NG,NG-dimethylarginine dimethylaminohydrolase in the nitric oxide-generating systems of rats using monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Gut and liver handling of asymmetric and symmetric dimethylarginine in the rat under basal conditions and during endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Acute Escherichia coli endotoxaemia decreases the plasma l-arginine/asymmetrical dimethylarginine ratio in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

The human liver clears both asymmetric and symmetric dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Plasma concentrations of nitric oxide and asymmetric dimethylarginine in human alcoholic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

A role for asymmetric dimethylarginine in the pathophysiology of portal hypertension in rats with biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Viral gene delivery of superoxide dismutase attenuates experimental cholestasis-induced liver fibrosis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Oxidative stress and apoptosis in fetal rat liver induced by maternal cholestasis. Protective effect of ursodeoxycholic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Role of oxidant stress in the permeability transition induced in rat hepatic mitochondria by hydrophobic bile acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

ADMA correlates with portal pressure in patients with compensated cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Elevation of asymmetric dimethylarginine (ADMA) in patients developing hepatic failure after major hepatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

The transplanted liver graft is capable of clearing asymmetric dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Presence of methylated arginine derivatives in orthotopic human liver transplantation: relevance for liver function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Accumulation of symmetric dimethylarginine in hepatorenal syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Levels of dimethylarginines and cytokines in mild and severe preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

No compensatory upregulation of placental dimethylarginine dimethylaminohydrolase activity in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Plasma concentrations of asymmetric dimethylarginine (ADMA) in Colombian women with pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

The asymmetrical dimethylarginine (ADMA)-multiple organ failure hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Reducing ventilator-induced lung injury and other organ injury by the prone position

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

The clinical pharmacology of L-arginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

L-Arginine therapy in cardiovascular pathologies: beneficial or dangerous?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Taurine and vitamin C modify monocyte and endothelial dysfunction in young smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Taurine suppresses development of atherosclerosis in Watanabe heritable hyperlipidemic (WHHL) rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

Preoperative supplementation with a carbohydrate mixture decreases organ dysfunction-associated risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0148607108321702

21 January 2018

Identifiers

DOI

10.1177/0148607108321702

1 reference

19 August 2017

1 reference